eMAX Health Systems published an article exploring why affordability policy will not necessarily make market access simpler and what manufacturers should prepare for now.
Public source
Publisher name
Public post
Drug pricing reform may change what a therapy costs. It does not eliminate the decisions that determine access. As Medicare negotiation and MFN pricing initiatives resha…
Company
eMAX Health Systems
Research Guided
- Industry
- Pharmaceutical Manufacturing
- Location
- Delray Beach, US
- Company size
- 11–50 employees
About eMAX Health Systems
eMAX Health Systems provides value-driven, global turnkey professional services to implement accountable care. eMAX Health Systems, LLC was established in 2004 to provide independent research and innovative pharmaceutical distribution support across various segments of the global healthcare system. eMAX Health offers independent outcomes monitoring, rebate adjudication, and administrative reporting services, bringing competing interests together to improve health outcomes and lower cost. eMAX Health Research and Analytics: Through an independent global analytics research team, we conduct comparative effectiveness research to assess the value of pharmaceutical products. eMAX Health Patient Access Center: Through a prescription drug patient access center, we help implement medical policy by managed care organizations to improve patient access to needed treatments.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
National Pharmaceutical Council
National Pharmaceutical Council published a guide explaining the risks of Upper Payment Limit (UPL) implementation, what's at stake, and the current landscape.
Research & Knowledge
Kintiga
Kintiga published the German AMNOG Orphan Tracker Report, a bi-monthly update designed to keep market access, evidence, and regulatory teams informed of the latest benefit assessments, pricing negotiations, and orphan medicine developments.
Research & Knowledge
Evimed
Evimed published a read by Necdet Gunsoy on the approach to helping HEOR, market access, and HTA teams adopt AI.
Research & Knowledge
RxE2
RxE2 published a thought leadership piece on how the pharmacy is leading the transformation of clinical trials to a community research hub.
Research & Knowledge
Arex Advisor